Navigating Brain Injury Clinical Trials
feat. Ross D. Zafonte, DO
Clinical trials are essential to advancing the field of brain injury treatment. Join Dr. Ross D. Zafonte, President of Spaulding Rehabilitation Network, Chairman of the Harvard Medical School Department of Physical Medicine & Rehabilitation (PM&R), and Chief of the Massachusetts General Hospital Department of PM&R, for a discussion about clinical trials and how people recovering from brain injury should approach clinical trial participation if they want to incorporate one into their recovery journey.
Ross D. Zafonte, DO
President of Spaulding Rehabilitation Network; Earle P. and Ida S. Charlton Professor; Chairman of Harvard Medical School Department of Physical Medicine & Rehabilitation (PM&R); Chief of Massachusetts General Hospital Department of PM&R
Dr. Ross D. Zafonte is an American board-certified physiatrist known for his academic work in traumatic brain injury and is recognized as an expert in his field. His textbook, Brain Injury Medicine, is considered one of the standards in the field of brain injury care. His work is presently funded by the NIH, DOD and NIDRR, and he is currently directing several large clinical treatment trials. His research primarily focuses on understanding mechanisms of recovery after Brain and Spinal Cord Injury. At the RedSox MGH Home Base program, he directs the Brain Injury and the Warrior Health and Fitness programs and at the Football Players Health Study at Harvard University, he is the Principal Investigator. Dr. Zafonte also sees patients in numerous clinics and hospitals in the Boston community including former NFL athletes as part of a special MGH initiative known as the Brain and Body Program. Dr. Zafonte has published extensively on traumatic brain injuries, spasticity, and other neurological disorders, as well as presented on these topics at conferences nationally and internationally. He is the author of more than 300 peer review journal articles, abstracts and book chapters. His most recent awards include the Innovative Clinical Treatment Award presented by the North American Brain Injury Society, the 2020 Distinguished Member Award from the American Academy of Physical Medicine and Rehabilitation, and a Public Service Medal from the United States Department of the Army for his work with military veterans.